Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy
Murali Kesavan, Jan Boucek, William MacDonald, Andrew McQuillan, J. Harvey Turner
Dive into the research topics of 'Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy'. Together they form a unique fingerprint.